Back to Treatments

Treatment

Triple Therapy (LAMA/LABA/ICS, e.g., Fluticasone furoate/Umeclidinium/Vilanterol)

1
Conditions
10
Trials
20K
Participants
48%
Average Safety

Condition Evidence

COPD

10 trials · 20K participants

70% effectiveness · 48% safety
Triple Therapy (LAMA/LABA/ICS, e.g., Fluticasone furoate/Umeclidinium/Vilanterol) | DFDA